Related by context. All words. (Click for frequent words.) 77 pancreatic prostate 77 LHRH receptor positive 75 demonstrated antitumor activity 75 kidney urologic 74 CYT# potent vascular disrupting 73 bladder ovarian 73 papillary renal cell carcinoma 73 breast endometrial 73 pancreatic lung 73 prostate carcinoma 73 lung pancreatic 72 BRCA1 BRCA2 72 KRAS oncogene 72 cisplatin resistant 72 mutated K ras 72 colorectal gastric 71 unresectable tumors 71 metastatic gastric 71 neovasculature 71 taxane resistant 71 metastatic colorectal 71 thyroid carcinoma 71 HER2 positive breast 71 Her2 positive 71 haematologic 71 ovarian pancreatic 71 leukemia multiple myeloma 71 K ras mutations 70 hematopoietic cancers 70 Squamous cell 70 refractory gastrointestinal stromal 70 KRAS mutated 70 nodal metastasis 70 treating sarcoma testicular 70 lymphoma myeloma 70 Colon polyps 70 gastric carcinoma 70 leukemias lymphomas 70 gastrointestinal stromal tumors GISTs 70 ovarian endometrial 70 polycythemia vera essential thrombocythemia 70 tryptase 70 SIADH 70 undergoing hematopoietic stem 70 hormonally sensitive 70 5 HT2A serotonin 70 Estrogen receptor positive 70 non mutated KRAS 70 squamous cell lung cancer 70 Vidaza ® 70 deCODE ProstateCancer TM 70 malignant ascites 70 invasive lobular 70 Ribavirin causes 70 pancreatic endocrine 70 refractory colorectal cancer 70 prostate ovarian 70 hormone refractory prostate 69 breast ovary 69 alpha1 antitrypsin deficiency 69 prostate carcinomas 69 colorectal pancreatic 69 localized prostate 69 allogeneic HSCT 69 bile duct cancers 69 impair fertility 69 BRAF mutant 69 cervical prostate 69 BRCA deficient 69 metastatic malignant 69 skeletal metastases 69 refractory Hodgkin 69 PLX STROKE targeting 69 Sudhir Agrawal D.Phil 69 antimitotic 69 cardiotoxic 69 castration resistant hormone refractory 69 malignant ovarian 69 relapsed ALL 69 pretransplant 69 potent inducer 69 HER2 expression 69 tumorigenicity 69 convulsive disorders 69 immuno modulatory 69 circulating endothelial cells 69 Alessandro Riva 69 nonmelanoma 69 syngeneic 69 immune modulating 69 relapsed MM 69 nonmetastatic 69 leukaemias 69 basal cell carcinoma squamous 69 gastric corpus 69 T1c 68 Basal Cell 68 heparanase 68 TNF blocker therapy 68 induced anemia 68 metastatic lymph nodes 68 oesophageal adenocarcinoma 68 Gleevec resistant 68 spontaneously regress 68 bladder cervix 68 ovarian lung 68 corticosteroid induced 68 endometrial breast 68 essential thrombocythemia ET 68 anthracycline chemotherapy 68 Intravenous immunoglobulin 68 hypereosinophilic syndrome 68 myelodysplastic myeloproliferative diseases 68 pancreatic colon 68 ovarian breast 68 deep venous thromboses 68 GRNOPC1 contains 68 cervical lymph nodes 68 colorectal adenocarcinoma 68 HER2 overexpression 68 novel VDA molecule 68 colorectal carcinoma 68 liver metastasis 68 fibrosarcoma 68 Ph + acute lymphoblastic 68 osteosarcomas 68 telomerase inhibition 68 receiving XGEVA 68 Leukemias 68 decompensated cirrhosis 68 colon rectum breast 68 cystic fibrosis chronic pancreatitis 68 Waldenstrom macroglobulinemia 68 fibroids endometriosis 68 pancreatic islet cell 68 urothelial cancer 68 detecting precancerous 68 ALK inhibitors 68 FUSILEV enhances 68 uterine tumors 68 deCODE BreastCancer 68 glial tumors 68 hematological diseases 68 tumor histology 68 redox active 68 AGTR1 68 multifactorial disease 68 oral squamous cell 68 ductal carcinomas 68 androgen dependent 68 recurrent epithelial ovarian 68 ® lenalidomide 68 Cathepsin B 68 untreated metastatic melanoma 68 transfusion syndrome 68 thymectomy 68 HIV HCV coinfected 68 fusion enhancers 68 malignant prostate 68 Undesirable alterations 68 Basal cell 68 metastatic neuroendocrine tumors 68 breast carcinoma 68 multiple sclerosis psoriasis 68 mucinous 68 HER2 neu 68 cervical lymph node 68 pancreatic ductal 68 leiomyomas 68 HER2 positive cancers 68 ovarian cervical 68 surgically resectable 68 potent suppressor 68 autoimmune uveitis 68 antisense inhibitors 67 Immunosuppressive 67 MAGE A3 ASCI 67 neurosensory 67 colorectum 67 renal carcinoma 67 hormone receptor negative 67 proliferative disorders 67 Tyrosine kinases 67 receptor inhibitor 67 radiosensitivity 67 intestinal polyps 67 precancerous condition 67 hepatocellular 67 untreated metastatic pancreatic 67 ovarian colon 67 severe hepatic dysfunction 67 immunosuppression therapy 67 Valproic acid 67 gastric cardia 67 Elevated serum 67 Known hypersensitivity 67 selective modulator 67 esophageal gastric 67 asthma rheumatoid arthritis 67 antiphospholipid antibodies 67 Platinol ® cisplatin 67 pelvic malignancies 67 promoter hypermethylation 67 bladder prostate 67 cryosurgery freezing 67 neuroendocrine cancers 67 adhesion molecule EpCAM expressing 67 oral picoplatin 67 hepatocellular carcinoma liver 67 sarcomatoid 67 advanced medullary thyroid 67 chronic thromboembolic pulmonary 67 R Saizen R 67 Endometrial 67 lung esophageal 67 motilin 67 metastatic bladder 67 p# MAP kinase inhibitor 67 gastric adenocarcinoma 67 adrenocortical cancer 67 recurrent ovarian 67 endocrine therapies 67 collagen vascular 67 smoldering myeloma 67 histological subtype 67 gefitinib Iressa 67 taxane chemotherapy administered 67 chronic eosinophilic leukemia 67 induced tumor regression 67 novel tubulin binding 67 Carcinoid tumors 67 humanised monoclonal antibody 67 Tß4 67 benign uterine 67 tumors GIST 67 tumor subtype 67 EGFR mutation positive 67 lactate dehydrogenase LDH 67 haematologic malignancies 67 TNF alpha antagonist 67 basal cell skin 67 bronchoalveolar lavage fluid 67 RRM1 67 fibrate drugs 67 Papillary 67 leukemia lymphomas 67 taxane refractory 67 deletion 5q 67 HuCNS SC ® 67 selectively inhibited 67 weekly subcutaneous injections 67 hypervascular tumors 67 recurrent glioblastoma multiforme 67 metastatic pancreatic 67 colorectal lung 67 Glioblastoma Multiforme GBM 67 diagnostic biomarker 67 Soy isoflavones 67 antiproliferative effects 67 castrate resistant 67 polycystic ovarian disease 67 trastuzumab Herceptin ® 67 platelet dysfunction 67 parathyroid carcinoma 67 prostate pancreatic 67 Darinaparsin 67 HER2 amplified 67 lymphoid tumors 67 prostate abnormalities 67 benign neoplasms 67 anti angiogenic agents 67 diabetic kidney 67 anthracycline taxane 67 MELAS 67 Leydig cell 67 humanized therapeutic 67 abnormal p# 67 inhibit platelet function 66 neovascularisation 66 benign prostatic hyperplasia enlarged 66 Genetic variations 66 chemo resistant 66 esophagus bladder 66 substantially excreted 66 sunitinib Sutent 66 Alequel 66 testicular tumors 66 mTOR inhibitors 66 potent antiproliferative 66 inverse agonist 66 Lenocta TM sodium stibogluconate 66 Lymph node 66 GnRH analogue 66 IMiDs ® 66 squamous cell carcinoma SCC 66 interleukin IL -# 66 BEXXAR Therapeutic Regimen 66 Refractory Hodgkin Lymphoma 66 malignant pancreatic 66 detect amyloid plaque 66 Immunotherapeutic 66 glutamic acid decarboxylase 66 epilepsy Parkinson disease 66 selective agonists 66 EGFR mutant 66 Li Fraumeni 66 hormonally responsive 66 Gorlin syndrome 66 incontinence erectile dysfunction 66 G CSFs 66 surgically resected 66 experimental therapeutics 66 dyslipidemia abnormal 66 BRAF V#E 66 advanced malignant hepatic 66 cardiovascular disease osteoporosis 66 Clusterin 66 Kinoid 66 Upregulation 66 CYP#A# CYP#D# 66 fibrocystic disease 66 melanoma ovarian 66 syncope fainting 66 Shows Promise Against 66 breast pancreatic 66 either acutely decompensated 66 oncogenic mutations 66 Prognostic factors 66 BPH benign prostatic 66 recurrent malignant glioma 66 anti gastrin monoclonal 66 apocrine 66 commercialize deforolimus 66 autosomal dominant polycystic kidney 66 antiphospholipid syndrome 66 gastric carcinomas 66 dysplastic lesions caused 66 lymphoid malignancies 66 Hurthle cell 66 hCG Beta 66 Enzastaurin 66 R lenalidomide 66 hypermethylated 66 membranous nephritis 66 histologic subtype 66 anastrazole 66 thyroid parathyroid 66 treat musculoskeletal metabolic 66 epithelial tumors 66 alkylating agent 66 immune dysregulation 66 hematological disorders 66 familial hypercholesterolemia FH 66 colorectal ovarian 66 granulosa cell 66 haematological cancers 66 myeloperoxidase 66 adenomatous 66 cisplatin gemcitabine 66 mineralocorticoid 66 mouse xenograft models 66 nonalcoholic steatohepatitis NASH 66 Evoltra ® 66 HER2 amplification 66 fibroma 66 bronchoalveolar 66 treating cancerous tumors 66 MCF7 66 myeloproliferative diseases 66 LRP5 66 Orally administered 66 Chlamydia trachomatis infection 66 BRAF gene mutations 66 acetonide FA 66 biliary tract 66 lactate dehydrogenase 66 endocrine tumors 66 lymphoproliferative disease 66 oncologic diseases 66 NSAID induced GI 66 benign prostatic hypertrophy 66 Tasigna prolongs 66 melanocortin receptor 66 dyslipidemia hypertension diabetes 66 leukemia AML 66 metaglidasen 66 mild renal insufficiency 66 prostate cancer CaP 66 grade squamous intraepithelial 66 Systemic lupus erythematosus 66 severe malignant osteopetrosis 66 biliary tract cancer 66 Darapladib 66 Clinically significant 66 antiangiogenic therapy 66 recurrent metastatic 66 Letairis ambrisentan 66 CTAP# 66 pediatric pontine glioma 66 neuroinflammatory diseases 66 chimeric monoclonal antibody 66 endometrial hyperplasia 66 Monoclonal antibody 66 ovary uterus 66 intravascular hemolysis 66 Amgen Neulasta ® 66 nonhereditary 66 Fibroblast 66 progesterone receptor negative 66 thalidomide Thalomid 66 Anti VEGF 66 multiple sclerosis lupus 66 renal cell carcinomas 66 Thalomid ® 66 urothelial carcinoma 66 HIF 1α 66 myeloproliferative neoplasms MPNs 66 treating neuropathic pain 66 abnormal pap smears 66 rhabdoid 66 elevated transaminases 66 included exfoliative dermatitis 66 AML MDS 66 Menopausal hormone therapy 66 reproductive endocrine 66 mitoxantrone plus 66 neuro developmental disorders 66 Actinic Keratosis 65 elevated prolactin 65 refractory metastatic 65 relapsed leukemia 65 vascular thrombosis 65 ovarian carcinoma 65 benign proliferative disorders 65 secondary hyperparathyroidism 65 aplasia 65 novel emulsion formulation 65 acadesine 65 GPC5 65 mutated p# 65 virally induced 65 Aplidin 65 infectious diseases autoimmune diseases 65 Histopathological 65 cervical breast 65 pAkt 65 ALB # 65 ovarian prostate 65 pathophysiological effects 65 HER2 expressing 65 maximally tolerated lipid lowering 65 mesangial 65 urethral stricture 65 neovascular diseases 65 Soft Tissue Sarcoma 65 Pathway Inhibitor 65 inhibiting telomerase 65 Angiotensin receptor blockers 65 refractory acute myeloid 65 eccrine 65 rheumatoid arthritis psoriatic arthritis 65 PCNSL 65 genitourinary tract 65 hyperphenylalaninemia HPA due 65 genitourinary cancers 65 lens opacities 65 novel therapeutic antibodies 65 Bayer HealthCare Onyx Pharmaceuticals 65 overexpress HER2 65 hormone receptor status 65 Shark cartilage 65 intracavitary 65 mGluR5 antagonist 65 decompensated liver disease 65 potentially hepatotoxic 65 primary hyperparathyroidism 65 treat enlarged prostate 65 cardio metabolic diseases 65 thromboembolic disease 65 intra arterial chemotherapy 65 normal karyotype 65 receptor tyrosine kinase inhibitor 65 psoriasis Crohn disease 65 interferon alpha IFN 65 TRIOLEX HE# APOPTONE HE# 65 histone deacetylase inhibitor 65 Adjuvant chemotherapy 65 pulmonary metastasis 65 malignant lymphomas 65 KRAS mutant 65 Heavy menstrual bleeding 65 HIV coinfected 65 Uterine cancer 65 Parathyroid hormone 65 systemic invasive fungal 65 cervix vagina 65 Factor Receptor 65 oral antidiabetic medication 65 leukemia myeloma 65 papillary carcinoma 65 antiangiogenic agent 65 colon ovarian 65 headache abdominal pain 65 non hodgkin lymphoma 65 metastatic GIST 65 efaproxiral 65 Anthracycline 65 MCSP respectively 65 immunopathology 65 chronic granulomatous disease 65 subependymal giant cell 65 endocrine dysfunction 65 atypical hemolytic uremic syndrome 65 malignant pheochromocytoma 65 lymphoid cancers 65 Adenomas 65 Testosterone deficiency 65 epithelial ovarian 65 adjuvant cisplatin 65 intracranial atherosclerosis 65 precancerous cervical 65 Commonly prescribed 65 phenothiazines 65 lenalidomide Revlimid R 65 androgen ablation 65 candidates Azedra TM 65 echocardiographic parameters 65 calcium antagonists 65 blood coagulation disorders 65 metastatic renal 65 Hedgehog inhibitor 65 infused intravenously 65 osteogenic 65 localized renal 65 node metastases 65 myopathies 65 anemia thrombocytopenia 65 de novo AML 65 ANCA associated 65 operable breast cancer 65 gastroesophageal 65 pulmonary hypertension PH 65 transgenic rats 65 neuro protective 65 Inhaled nitric oxide 65 bronchoalveolar lavage BAL 65 myelomas 65 Heterozygous Familial Hypercholesterolemia 65 visit www.rtanswers.org 65 mTOR mammalian target 65 ductal adenocarcinoma 65 antisense inhibition 65 mycophenolic acid 65 inhibiting COX 65 Neurofibromatosis type 65 Magnesium deficiency 65 bony metastases 65 Genetic variants 65 estradiol gel indicated 65 MediGene focuses 65 hepatic tumors 65 Amgen Neulasta R 65 endometrial tumors 65 nonalcoholic steatohepatitis 65 induced mucositis 65 neurofibrillary 65 treat benign prostatic 65 trophoblastic 65 subclinical disease 65 chronic idiopathic thrombocytopenic purpura 65 thetreatment 65 VEGF induced 65 TTR amyloidosis 65 Acute myeloid leukemia 65 colorectal adenoma 65 iPS derived 65 Islet cells 65 MGd 65 hematologic malignancy 65 esophagus colon 65 beta1 integrin 65 CP CPPS 65 psoriasis inflammatory bowel 65 Topoisomerase II 65 Prednisone Against Refractory 65 fibrin deposition 65 thalassemia sickle cell 65 leukemia lymphoma multiple myeloma 65 radiation chemoradiation 65 benign prostatic hypertrophy BPH 65 lymphangiogenesis 65 colorectal neoplasms 65 neoadjuvant setting 65 lymphoproliferative disorders 65 Chronic lymphocytic leukemia 65 antiangiogenic drugs 65 cytotoxic therapies 65 antiangiogenesis 65 treatmentof 65 monoclonal antibody conjugated 65 pain palliation 65 muscular dystrophy cystic fibrosis 65 transthyretin amyloidosis 65 metastatic prostate 65 carcinoma HCC 65 XL# inhibits 65 pancreas esophagus 65 hypokalemia hypomagnesemia 65 hamartomas 65 spontaneous regression 65 Endometrial cancer 65 hepatorenal syndrome 65 peritoneal carcinomatosis 65 including eniluracil ADH 65 Erythropoietic therapies may 65 baseline LDH 65 thyrotropin 65 hMG 65 Systemic lupus erythematosus SLE 65 PCA3 gene 65 dyskeratosis congenita 65 survivin expression 65 chronic myeloid 65 locoregional recurrence 65 smoldering multiple myeloma 65 prostate cancer benign prostatic 65 glaucoma ischemia 65 potently inhibited 65 ® bortezomib 65 IMiDs R 65 levodopa induced 65 leptin deficiency 65 cMET 65 lupus multiple sclerosis 65 pediatric malignancies 65 pancreatic neuroendocrine 65 carcinoids originate 65 TNF Tumor Necrosis Factor 65 galiximab 65 completely resected 65 Androgen deprivation therapy 65 lymph node enlargement 65 CD#c 65 Chronic lymphocytic leukemia CLL 65 metastatic adenocarcinoma 65 #beta HSD1 65 testicular germ cell 65 dasatinib Sprycel 65 5 HT1A receptor 65 TNF Blockers 65 transarterial 65 Inflammatory diseases 65 refractory chronic lymphocytic 65 bronchogenic carcinoma 65 Squamous 65 enlarged prostate BPH 65 Prostatitis 64 hyperplasia BPH 64 cutaneous lupus 64 humanised antibody 64 hormone FSH 64 pituitary adenomas 64 impaired insulin secretion 64 DNA methyltransferase inhibitors 64 chronic obstructive airway 64 Thrombotic thromboembolic complications 64 targeted nucleotide prodrug 64 vitreous floaters 64 prokinetic agent 64 finasteride Proscar 64 metaplasia 64 hypothalamic pituitary 64 Triapine R 64 transrectal ultrasound guided 64 INSPIRE Trial Phase III 64 blood clot dissolving 64 vaso occlusive crisis 64 arteriovenous malformations 64 tubulin inhibitor 64 LHRH agonists 64 TMPRSS2 ERG fusion 64 VEGF inhibitors 64 NKX#.# 64 hematopoietic malignancies 64 precancerous prostate 64 chemotherapy cisplatin 64 p# Shc 64 bronchodilatory 64 neuro degenerative disorders 64 tamoxifen Nolvadex ® 64 urothelial 64 recurrent bladder 64 nonsmall cell lung cancer 64 idiopathic pulmonary 64 renoprotective 64 Virulizin ® 64 acute myeloid 64 Smac mimetic 64 microtubule inhibitor 64 non resectable metastatic 64 nonnucleoside reverse transcriptase inhibitors 64 beta carotene supplementation 64 upregulates 64 Chronic pancreatitis 64 Cloretazine R 64 intrahepatic 64 CB2 receptor 64 thromboxane A2 64 ERalpha 64 BRAF V#E mutation 64 rheumatoid arthritis lupus 64 Immunohistochemical staining 64 esophagus pancreas 64 choroidal vasculopathy 64 colon carcinomas 64 lumbar disk herniation 64 nonvascular 64 known sulfonamide allergy 64 invasive lobular carcinoma 64 clinico pathological 64 cytokines chemokines 64 shorter telomere length 64 oral clodronate 64 UVB induced 64 SGPT 64 diagnose coronary artery 64 fallopian tube cancers 64 intact parathyroid hormone 64 breast uterine 64 chemosensitizer 64 anti nogo 64 drug Treanda 64 monoclonal anti 64 vaginal candidiasis 64 lesional 64 Hematologic 64 CEACAM1 64 exocrine 64 gastrointestinal mucositis 64 endocrine abnormalities 64 experimentally induced 64 Peptide YY 64 antiretroviral naïve 64 sinonasal 64 immunomodulatory properties 64 erythema nodosum 64 IMiDs ® compound 64 ADVEXIN therapy 64 estrogen receptor beta agonist 64 monogenic 64 triggers apoptosis programmed 64 uterus fallopian tubes 64 squamous carcinoma 64 protein tyrosine phosphatase 1B 64 R abatacept 64 radiolabeled TM# 64 p# alpha [001] 64 Plaquenil 64 neuritic 64 primary dysmenorrhea 64 tumor metastases 64 gastrointestinal stromal 64 basal cell carcinoma BCC 64 enlarged spleens 64 retinal vein occlusion induced 64 chronic lymphocytic 64 induce apoptosis programmed 64 Kit CD# positive 64 MYCN amplification 64 basal epithelial 64 potently inhibit 64 TÎ ² 4 64 teratogens 64 rheumatoid arthritis inflammatory bowel 64 receiving chemoradiation therapy 64 VEGF expression 64 underwent prostate biopsy 64 idiopathic thrombocytopenic purpura 64 homozygous FH 64 steroid refractory 64 chemoprotective 64 inhibitor COX 64 p# biomarker 64 R sorafenib tablets 64 cardiometabolic disorders 64 ovarian colorectal 64 chromosomal rearrangement 64 uterine cervix 64 von Willebrand 64 obstructive coronary 64 unconjugated 64 produces radioisotopes 64 ErbB2 positive 64 targets EpCAM expressing 64 cells multiply uncontrollably 64 cause cardiac channelopathies 64 thromboembolisms 64 GH deficiency 64 ospemifene 64 myeloproliferative disorders 64 Diffuse Large B 64 seminomas 64 mTOR inhibition 64 transthyretin 64 Subgroup analysis 64 chemopreventive agent 64 Atypical Hemolytic Uremic Syndrome 64 pancreatic adenocarcinoma 64 thyroid deficiency 64 prostate bladder 64 Urinary tract 64 Epstein Barr Virus EBV 64 noninvasive outpatient 64 SSc 64 myelofibrosis polycythemia vera 64 Squalamine 64 pulmonary alveolar 64 prognostic biomarker 64 Mg Uk 64 MTP inhibitor 64 malignant brain 64 GSTP1 64 invasive carcinoma 64 HUMIRA resembles 64 pan genotypic 64 nutlin 3a 64 complement inhibitor eculizumab 64 receiving VELCADE 64 acid phosphatase PAP 64 cutaneous melanoma 64 Gemzar gemcitabine 64 osteoprotegerin 64 MTHFD1L gene 64 Sjögren syndrome 64 Malignant glioma 64 atypical hyperplasia 64 containing abacavir 64 Ischemic 64 uterine fibroids endometriosis 64 Budesonide foam crofelemer 64 Malignant Glioma 64 HMG CoA reductase inhibitors 64 OGG1 64 anemia neutropenia 64 neutropenic sepsis 64 GVAX ® 64 mouse mammary 64 Brodmann Area 64 DITPA 64 B7 H3 64 cystic ovaries 64 colo rectal 64 hepatocellular carcinomas 64 Amgen denosumab 64 thymidylate synthase 64 JAK2 enzyme 64 neoplastic diseases 64 pharynx larynx 64 orally administered inhibitor 64 peri implant 64 reproductive abnormalities 64 liver transaminases 64 molecular abnormalities 64 pancreatic alpha 64 anti atherothrombotic 64 edifoligide E2F Decoy 64 Progressive Multifocal Leukoencephalopathy 64 GATA3 64 endometriosis ovarian cysts 64 erythropoietic 64 ABCB1 64 colon rectal 64 lung ovary 64 NMIBC 64 Hepatocellular Carcinoma HCC 64 medullary thyroid 64 EGFR HER2 64 CYP#D# gene 64 Nicole Onetto MD 64 cytogenic 64 Akt activation 64 prostatic hyperplasia 64 unexplained vaginal bleeding 64 chromosomal aberrations 64 precursor lesions 64 Aeolus Pharmaceuticals Announces 64 immunologic diseases 64 post transplant lymphoproliferative 64 colon pancreas 64 Lymphoid 64 PDGFRA 64 Protein Kinase C 64 left ventricular diastolic 64 inhibit blood clotting 64 micrometastasis 64 leiomyoma 64 pancreatic ovarian 64 HepDirect prodrug 64 antiangiogenesis therapies 64 ß blockers 64 #ß HSD1 64 congenital deficiency 64 Patients Treated With 64 hypervascular 64 somatostatin receptor 64 Dr. Ivashkiv 64 HGS ETR1 mapatumumab 64 hypercalcaemia 64 elevated fasting glucose 64 torsade de pointes 64 subcutaneous immunoglobulin 64 whose tumors overexpress 64 ADPKD 64 abnormal genital 64 Hepatocellular 64 small molecule tyrosine 64 aurora kinase 64 DCVax R 64 NQO1 64 GRN# 64 Histopathologic examination 64 mutated KRAS gene 64 mediated inhibition 64 pharmacogenomic translational research 64 tongue mouth pharynx 64 pituitary adenoma 64 hip osteonecrosis avascular 64 hepatic enzyme 64 renal cysts 64 null responder 64 accumulate preferentially 64 interstitial fibrosis 64 chemosensitivity 64 antiangiogenic activity 64 reduce serum phosphate 64 chronic leukemias 64 nonmelanoma skin cancers 64 EGFR blockers 64 PI3K/Akt pathway inhibitor 64 treat chronic sinusitis 64 hereditary predisposition 64 lung cancer NSCLC 64 refractory myeloma 64 alvespimycin 64 cisplatin chemotherapy 64 mild hepatic impairment 64 flavopiridol 64 minimally symptomatic 64 monocytic 64 stratifying patients 64 ERK signaling 64 pro angiogenic 64 HER2 positivity 64 benign noncancerous 64 metastatic uveal melanoma 64 hepatoma 64 gene polymorphism 64 prostate adenocarcinoma 64 von Hippel Lindau 64 Gall bladder 64 systemic mastocytosis 64 mucosal inflammation 64 advanced metastatic renal 64 Bucindolol 64 lupus scleroderma 64 opioid tolerant adult 64 resectable pancreatic cancer 64 lichen planus 64 haematopoietic 63 prostanoid 63 transthyretin TTR 63 novel antimitotic agent 63 CellCept mycophenolate mofetil 63 coagulation disorders 63 Warfarin Coumadin 63 androgen hormone 63 adrenocortical 63 multiple myeloma MM 63 peritoneal fluid 63 patients receiving myelosuppressive 63 GRNCM1 63 inhibits VEGF 63 SOD2 gene 63 mesenteric 63 psoriatic arthritis PsA 63 haematopoietic stem cell 63 CTEPH 63 chemoresistant 63 Fanconi syndrome 63 delay bone metastases 63 adrenal suppression 63 lymphocytic leukemia 63 Histone deacetylase 63 autologous transplantation 63 aMCI precursor 63 micro calcifications 63 basiliximab 63 Inflammatory bowel diseases 63 Adenoviral